Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 31  •  04:00PM ET
862.86
Dollar change
+18.36
Percentage change
2.17
%
IndexS&P 500 P/E42.67 EPS (ttm)20.22 Insider Own10.21% Shs Outstand945.84M Perf Week4.53%
Market Cap815.73B Forward P/E28.01 EPS next Y30.80 Insider Trans-1.51% Shs Float848.86M Perf Month5.25%
Enterprise Value848.38B PEG1.01 EPS next Q7.02 Inst Own73.84% Short Float0.81% Perf Quarter12.21%
Income18.41B P/S13.73 EPS this Y78.26% Inst Trans-0.45% Short Ratio1.52 Perf Half Y4.76%
Sales59.42B P/B34.30 EPS next Y33.01% ROA19.33% Short Interest6.84M Perf YTD11.77%
Book/sh25.16 P/C82.29 EPS next 5Y42.09% ROE96.82% 52W High935.62 -7.78% Perf Year-4.51%
Cash/sh10.49 P/FCF87.98 EPS past 3/5Y24.14% 18.77% ROIC28.47% 52W Low623.78 38.33% Perf 3Y141.12%
Dividend Est.5.86 (0.68%) EV/EBITDA29.99 Sales past 3/5Y16.73% 15.08% Gross Margin83.03% Volatility3.12% 2.52% Perf 5Y508.93%
Dividend TTM5.80 (0.67%) EV/Sales14.28 EPS Y/Y TTM88.21% Oper. Margin44.41% ATR (14)22.55 Perf 10Y1001.85%
Dividend Ex-DateNov 14, 2025 Quick Ratio1.24 Sales Y/Y TTM45.41% Profit Margin30.99% RSI (14)66.72 Recom1.58
Dividend Gr. 3/5Y15.21% 15.05% Current Ratio1.55 EPS Q/Q479.29% SMA204.34% Beta0.42 Target Price946.33
Payout44.39% Debt/Eq1.79 Sales Q/Q53.87% SMA5010.55% Rel Volume1.11 Prev Close844.50
Employees47000 LT Debt/Eq1.72 EarningsOct 30 BMO SMA2009.38% Avg Volume4.51M Price862.86
IPOJul 09, 1970 Option/ShortYes / Yes EPS/Sales Surpr.23.33% 9.64% Trades Volume5,009,494 Change2.17%
Date Action Analyst Rating Change Price Target Change
Oct-20-25Reiterated BMO Capital Markets Outperform $840 → $930
Oct-14-25Upgrade Erste Group Hold → Buy
Sep-17-25Downgrade Berenberg Buy → Hold $830
Aug-27-25Upgrade HSBC Securities Reduce → Hold $700
Aug-18-25Downgrade Daiwa Securities Outperform → Neutral $700
Aug-07-25Downgrade Leerink Partners Outperform → Market Perform $715
Jun-05-25Downgrade Erste Group Buy → Hold
Apr-28-25Downgrade HSBC Securities Buy → Reduce $1150 → $700
Apr-22-25Initiated Cantor Fitzgerald Overweight $975
Dec-10-24Resumed BofA Securities Buy $997
Nov-01-25 03:29PM
08:05AM
07:57AM
07:00AM
Oct-31-25 06:00PM
05:54PM Loading…
05:54PM
05:30PM
05:12PM
01:38PM
12:30PM
11:04AM
10:28AM
09:42AM
08:03AM
07:50AM
07:09AM Loading…
07:09AM
02:45AM
01:30AM
Oct-30-25 09:05PM
07:53PM
07:53PM
06:53PM
06:00PM
05:23PM
04:52PM
04:41PM
04:41PM
04:35PM
04:15PM
04:09PM
03:46PM Loading…
03:46PM
02:30PM
02:11PM
01:50PM
01:31PM
01:10PM
12:57PM
12:12PM
11:10AM
10:51AM
10:41AM
10:39AM
10:38AM
10:30AM
10:25AM
10:08AM
09:36AM
09:25AM
09:22AM
09:09AM
08:34AM
08:28AM
08:25AM
08:20AM
08:19AM
08:09AM
07:57AM
07:55AM
07:51AM
07:22AM
07:20AM
07:11AM
07:04AM
06:53AM
06:45AM
06:32AM
06:31AM
05:47AM
05:20AM
05:08AM
04:29AM
Oct-29-25 07:00PM
04:45PM
04:33PM
04:15PM
02:51PM
02:25PM
11:52AM
11:40AM
10:30AM
09:31AM
08:22AM
08:11AM
07:00AM
06:20AM
04:40AM
04:10AM
04:00AM
Oct-28-25 11:22PM
10:31PM
08:10PM
06:54PM
06:54PM
05:56PM
05:01PM
04:42PM
04:23PM
04:11PM
04:04PM
02:31PM
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LILLY ENDOWMENT INC10% OwnerOct 10 '25Sale863.243,6583,157,72294,533,320Oct 14 04:00 PM
LILLY ENDOWMENT INC10% OwnerOct 09 '25Sale852.4910,6029,038,05594,536,978Oct 10 04:00 PM
LILLY ENDOWMENT INC10% OwnerOct 10 '25Proposed Sale855.35305,000260,881,750Oct 10 02:57 PM
LILLY ENDOWMENT INC10% OwnerOct 08 '25Sale850.27101,42086,234,87494,547,580Oct 09 04:00 PM
LILLY ENDOWMENT INC10% OwnerOct 07 '25Sale848.0126,79522,722,40194,649,000Oct 08 04:00 PM
LILLY ENDOWMENT INC10% OwnerOct 06 '25Sale850.22161,183137,041,65794,675,795Oct 07 04:00 PM
LILLY ENDOWMENT INC10% OwnerOct 03 '25Sale837.93192,404161,220,40194,836,978Oct 06 04:00 PM
LILLY ENDOWMENT INC10% OwnerOct 06 '25Proposed Sale839.87300,000251,961,000Oct 06 03:35 PM
LILLY ENDOWMENT INC10% OwnerOct 02 '25Sale821.55112,59692,503,36195,029,382Oct 03 04:00 PM
LILLY ENDOWMENT INC10% OwnerOct 01 '25Sale821.47215,822177,290,44895,141,978Oct 02 04:56 PM
LILLY ENDOWMENT INC10% OwnerOct 01 '25Sale794.15135,193107,363,01695,357,800Oct 02 04:55 PM
LILLY ENDOWMENT INC10% OwnerOct 02 '25Proposed Sale825.42305,000251,753,100Oct 02 03:20 PM
LILLY ENDOWMENT INC10% OwnerOct 01 '25Proposed Sale763.00295,000225,085,000Oct 01 04:08 PM
LILLY ENDOWMENT INC10% OwnerSep 30 '25Sale763.39113,69486,793,27495,492,993Oct 01 04:00 PM
LILLY ENDOWMENT INC10% OwnerSep 19 '25Sale763.1023,66518,058,64395,606,687Sep 22 04:00 PM
LILLY ENDOWMENT INC10% OwnerSep 18 '25Sale764.65106,62681,531,95995,630,352Sep 19 04:00 PM
LILLY ENDOWMENT INC10% OwnerSep 18 '25Proposed Sale760.13300,000228,039,000Sep 18 03:04 PM
DONALD ZAKROWSKIOfficerAug 28 '25Proposed Sale734.172,0001,468,340Aug 28 04:19 PM
Zakrowski Donald ASVP, Finance, & CAOAug 28 '25Sale734.931,000734,9303,840Aug 28 04:14 PM
Montarce LucasEVP & CFOAug 15 '25Buy691.79715494,62714,685Aug 15 04:13 PM
Alvarez RalphDirectorAug 13 '25Buy660.25758500,473758Aug 14 04:12 PM
Van Naarden JacobEVP & Pres., Lilly OncologyAug 13 '25Buy647.361,000647,36020,562Aug 13 04:15 PM
Ricks David APresident, Chair, and CEOAug 12 '25Buy644.771,6321,052,263546,601Aug 12 04:23 PM
Skovronsky DanielEVP, CSO & Pres. LRL & LLY ImmAug 12 '25Buy634.401,000634,405137,660Aug 12 04:20 PM
Sulzberger GabrielleDirectorAug 12 '25Buy641.1811775,0182,703Aug 12 04:19 PM
Fyrwald J ErikDirectorAug 12 '25Buy642.331,5651,005,24274,578Aug 12 04:17 PM
Yuffa IlyaEVP&Pres, LLY USA&Global CapabAug 11 '25Sale627.011,250783,76226,260Aug 12 04:16 PM
JACKSON JAMEREDirectorAug 08 '25Buy639.56200127,9139,402Aug 08 04:20 PM
Seymour MelissaEVP, Global QualityAug 01 '25Option Exercise0.009520952Aug 04 04:16 PM
LILLY ENDOWMENT INC10% OwnerJul 24 '25Sale805.07280,000225,419,25995,736,978Jul 25 04:00 PM
LILLY ENDOWMENT INC10% OwnerJul 24 '25Proposed Sale798.89280,000223,689,200Jul 24 03:01 PM
Zakrowski Donald ASVP, Finance, & CAOMay 27 '25Sale716.411,000716,4104,840May 27 04:13 PM
Yuffa IlyaEVP & President, LLY Int'lMay 14 '25Sale749.241,250936,55027,510May 15 04:17 PM
Yuffa IlyaOfficerMay 14 '25Proposed Sale749.242,5001,873,100May 14 12:25 PM
DONALD ZAKROWSKIOfficerMar 13 '25Proposed Sale821.862,0001,643,720Mar 13 04:57 PM
Zakrowski Donald ASVP, Finance, & CAOMar 13 '25Sale818.241,000818,2405,840Mar 13 04:17 PM
LILLY ENDOWMENT INC10% OwnerMar 03 '25Sale928.76220,000204,326,15196,016,978Mar 04 04:00 PM
Dozier EricEVP, Chief People OfficerMar 01 '25Option Exercise0.002,403010,905Mar 03 04:53 PM
Hernandez EdgardoEVP & Pres., Mfg. OperationsMar 01 '25Option Exercise0.002,837041,009Mar 03 04:51 PM
LILLY ENDOWMENT INC10% OwnerMar 03 '25Proposed Sale920.63220,000202,538,600Mar 03 03:34 PM
LILLY ENDOWMENT INC10% OwnerFeb 25 '25Sale903.07225,000203,190,79496,236,978Feb 26 04:00 PM
LILLY ENDOWMENT INC10% OwnerFeb 24 '25Sale883.9760,43253,419,95596,461,978Feb 25 04:00 PM
LILLY ENDOWMENT INC10% OwnerFeb 25 '25Proposed Sale881.40225,000198,315,000Feb 25 03:05 PM
LILLY ENDOWMENT INC10% OwnerFeb 21 '25Sale882.7099,45287,786,50596,522,410Feb 24 04:00 PM
LILLY ENDOWMENT INC10% OwnerFeb 20 '25Sale877.9914,68512,893,35396,621,862Feb 21 04:00 PM
LILLY ENDOWMENT INC10% OwnerFeb 19 '25Sale878.459,9858,771,28596,636,547Feb 20 04:00 PM
LILLY ENDOWMENT INC10% OwnerFeb 13 '25Sale879.5235,44631,175,39696,646,532Feb 14 04:00 PM
LILLY ENDOWMENT INC10% OwnerFeb 13 '25Proposed Sale872.97220,000192,053,400Feb 13 03:43 PM
Skovronsky DanielEVP, CSO & Pres. LRL & LLY ImmFeb 10 '25Sale863.215,0004,316,065117,888Feb 12 04:15 PM
Skovronsky DanielOfficerFeb 10 '25Proposed Sale863.195,0004,315,954Feb 10 11:44 AM
LILLY ENDOWMENT INC10% OwnerFeb 06 '25Sale874.13210,000183,567,26296,681,978Feb 07 04:00 PM
LILLY ENDOWMENT INC10% OwnerFeb 06 '25Proposed Sale842.18210,000176,857,800Feb 06 04:04 PM
Yuffa IlyaEVP & President, LLY Int'lFeb 01 '25Option Exercise0.003,269023,071Feb 04 04:28 PM
White Anne E.EVP & Pres, Lilly NeuroscienceFeb 01 '25Option Exercise0.003,269068,838Feb 04 04:27 PM
Van Naarden JacobEVP & Pres., Lilly OncologyFeb 01 '25Option Exercise0.003,023014,868Feb 04 04:26 PM
Skovronsky DanielEVP, CSO & Pres. LRL & LLY ImmFeb 01 '25Option Exercise0.008,9890126,892Feb 04 04:25 PM
Ricks David APresident, Chair, and CEOFeb 01 '25Option Exercise0.0026,5610496,385Feb 04 04:24 PM
Rau DiogoEVP & CIDOFeb 01 '25Option Exercise0.003,269014,370Feb 04 04:23 PM
Jonsson PatrikEVP&Pres, CardMetHlth, LLY USAFeb 01 '25Option Exercise0.003,433048,016Feb 04 04:23 PM
Hernandez EdgardoEVP & Pres., Mfg. OperationsFeb 01 '25Option Exercise0.002,861033,479Feb 04 04:21 PM
Hakim AnatEVP, GC & SecretaryFeb 01 '25Option Exercise0.004,904020,683Feb 04 04:19 PM
Zakrowski Donald AOfficerNov 08 '24Proposed Sale803.38900723,042Nov 08 04:54 PM
Zakrowski Donald ASVP, Finance, & CAONov 08 '24Sale803.38900723,0425,480Nov 08 04:18 PM